View
comments
COVID-19 survivors may be more protected with only one vaccine dose than those who never contracted the virus are with two doses, a new study finds.
Researchers from Rush University in Chicago, Illinois, compared vaccine antibody levels among people with and without natural COVID immunity.
They found that people previously infected with the virus had antibody levels twice as high after one dose compared to those not previously infected with two doses.
What's more, antibody levels did not increase much between dose one and dose two for COVID-19 survivors.
This means the world may be able to save doses, at least in the short term, by giving former Covid patients only one dose.
Researchers found that COVID-survivors are developing higher antibody levels after only shot than others are after receiving both
Researchers, who published their findings Friday in JAMA Network
